Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Women's health
Biotech
Bayer to take menopause drug to regulators after 3rd ph. 3 win
Bayer's hot flash drug has struck phase 3 gold again, setting up the pharma to approach regulators about following Astellas’ Veozah to market.
James Waldron
Mar 19, 2024 7:17am
Biden directs agencies to boost R&D for women's health
Mar 18, 2024 11:07am
Biden asks Congress for $12B to fund women's health research
Mar 8, 2024 10:25am
Hologic harnesses FDA nod for AI-powered Pap test analysis
Feb 2, 2024 10:08am
BD taps Techcyte to bring AI to Pap smear tests
Jan 31, 2024 11:58am
FDA clears vibrating belt to boost brittle bones
Jan 22, 2024 9:09am